Works matching IS 03407004 AND DT 2017 AND VI 66 AND IP 3
Results: 12
Prognostic significance of the lymphocyte-to-monocyte ratio and the tumor-infiltrating lymphocyte to tumor-associated macrophage ratio in patients with stage T3N0M0 esophageal squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 3, p. 343, doi. 10.1007/s00262-016-1931-5
- By:
- Publication type:
- Article
Histone deacetylase inhibitors deplete myeloid-derived suppressor cells induced by 4T1 mammary tumors in vivo and in vitro.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 3, p. 355, doi. 10.1007/s00262-016-1935-1
- By:
- Publication type:
- Article
A polymorphism in the promoter region of PD-L1 serves as a binding-site for SP1 and is associated with PD-L1 overexpression and increased occurrence of gastric cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 3, p. 309, doi. 10.1007/s00262-016-1936-0
- By:
- Publication type:
- Article
Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 3, p. 367, doi. 10.1007/s00262-016-1937-z
- By:
- Publication type:
- Article
Targeting of the WT1 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 3, p. 319, doi. 10.1007/s00262-016-1938-y
- By:
- Publication type:
- Article
Selective effect of cytokine-induced killer cells on survival of patients with early-stage melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 3, p. 299, doi. 10.1007/s00262-016-1939-x
- By:
- Publication type:
- Article
Preventive DNA vaccination against CEA-expressing tumors with anti-idiotypic scFv6.C4 DNA in CEA-expressing transgenic mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 3, p. 333, doi. 10.1007/s00262-016-1940-4
- By:
- Publication type:
- Article
Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 3, p. 379, doi. 10.1007/s00262-016-1941-3
- By:
- Publication type:
- Article
Bio-HMGB1 from breast cancer contributes to M-MDSC differentiation from bone marrow progenitor cells and facilitates conversion of monocytes into MDSC-like cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 3, p. 391, doi. 10.1007/s00262-016-1942-2
- By:
- Publication type:
- Article
T cell receptor gene recombinations in human tumor specimen exome files: detection of T cell receptor-β VDJ recombinations associates with a favorable oncologic outcome for bladder cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 3, p. 403, doi. 10.1007/s00262-016-1943-1
- By:
- Publication type:
- Article
Acknowledgement.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 3, p. 411, doi. 10.1007/s00262-017-1956-4
- Publication type:
- Article
Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatment.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 3, p. 281, doi. 10.1007/s00262-016-1914-6
- By:
- Publication type:
- Article